EXELTIS is the fruit of the natural evolution and sustained growth of the CHEMO Group´s branded pharmaceutical business. Chemo is an international group that develops, manufactures and sells active pharmaceutical ingredients and formulations. It has direct presence in more than 40 countries and a wide-ranging portfolio of brands, joint ventures, and industrial facilities.
EXELTIS with a solid structure has nearly 4,000 professionals which it operates through a network of over 30 affiliates spread throughout the world.
It is a global organization with an enormous capacity for discovering, developing, producing and marketing medicines and health products that can help improve the quality of life of millions of people.
EXELTIS has a broad, diverse portfolio of almost 300 drugs that encompass a number of priority therapeutic areas, such as Women´s Health, Respiratory System, Dermatology, Cardiology, Central Nervous System, Ophthalmology, Oncology, Gastroenterology, Anti-Infective Drugs and Endocrinology, among others.
The organization has a strong position in the Women´s Health market, with a product offering that covers women´s needs in all stages of life. And also in other areas, such as Respiratory System, where it seeks to improve the health of patients with respiratory diseases, offering a range of oral and inhaled preparations. And also significant commitment to the development and marketing of innovative therapies in dermatology.
Our human team shares a series of values that makes it unique while at the same time giving as common purpose to the organization: EXELTIS is an exaltation of excellence, innovation and diversity.
